Skip to content
LIVE · CORPUS
Dossier

Versant Venture Capital VI, L.P.

Low
PersonUS
The finding

Controls or directs 14 companies in the resolved graph.

/01

Key facts

Risk signal
Controls
14 companies
Risk
Low
Jurisdiction
US

Versant Venture Capital VI, L.P. controls or directs 14 companies (US).

/02

Control & directorships

Controlled by

None in current sources.

Directorships & controlled companies
/03

Directorship network

746 other roles

Where this entity’s officers also hold (or held) positions — the wider network reached through shared people. Roles are registry records, not a claim of control.

LAVA Therapeutics NV
LENZ Therapeutics, Inc.
Monte Rosa Therapeutics, Inc.
Tempest Therapeutics, Inc.
Black Diamond Therapeutics, Inc.
Contineum Therapeutics, Inc.
OYSTER POINT PHARMA, INC.
Century Therapeutics, Inc.
Repare Therapeutics Inc.
Aligos Therapeutics, Inc.
Akero Therapeutics, Inc.
PANDION THERAPEUTICS HOLDCO LLC
Passage BIO, Inc.
/ Community notesFREE

Analyst context the registries don’t carry — corrections, links, open questions on Versant Venture Capital VI, L.P.. Notes are community-contributed leads, not verified facts.

Loading notes…